獸醫骨科植入物市場機會、成長動力、產業趨勢分析及 2025-2034 年預測

2024 年全球獸醫骨科植入物市場價值為 6.17 億美元，預計 2025 年至 2034 年期間的複合年成長率為 7.7%。動物骨科疾病和肌肉骨骼損傷盛行率的上升是推動市場成長的關鍵因素。隨著越來越多的寵物和牲畜出現行動不便的問題，對先進手術解決方案的需求持續激增。獸醫專業人員擴大採用骨科植入物來改善治療效果，而植入物材料和設計的技術進步也提高了手術的精確度。

寵物主人越來越關注寵物的健康，這推動了對專門骨科手術的需求。隨著診斷能力的提高，人們對治療方案的認知不斷提高，導致獸醫植入物的採用率更高。接受過骨科手術培訓的獸醫數量的增加以及擁有先進手術能力的獸醫診所的擴張正在進一步加速市場擴張。此外，涵蓋骨科手術的寵物保險政策的增加鼓勵寵物主人選擇手術，進一步推動了獸醫骨科植入物的採用。

植入物領域佔據了市場主導地位，2024 年市場規模達到 4.01 億美元，這主要是由於對患有骨科損傷的動物進行手術干預的需求不斷成長。獸醫專業人員越來越依賴鋼板、骨螺釘、關節植入物和其他手術器械來治療骨折、韌帶撕裂和關節疾病。針對這些情況的治療程序不斷增加，推動了對先進植入物設計的需求，這些設計可以提供更高的精度、縮短恢復時間並增強接受治療的動物的活動能力。微創手術技術越來越受到人們的關注，因為它們為治療肌肉骨骼疾病提供了更有效的解決方案，並減少了術後併發症。

受寵物收養量大幅增加的推動，伴侶動物在 2024 年佔據獸醫骨科植入物市場 72.5% 的主導佔有率。隨著全球越來越多的家庭飼養寵物，尤其是狗和貓，獸醫護理的支出也隨之增加。寵物主人在骨科治療方面投入更多資金，以改善寵物的生活品質，從而導致對專用植入物的需求增加。寵物人性化的趨勢——主人將動物視為家庭成員——進一步促進了市場擴張。

北美引領全球市場，2024 年佔 45.2% 的佔有率，這得益於高寵物擁有率和先進的獸醫醫療保健基礎設施。該地區擁有大量配備最先進手術技術的專業獸醫診所和醫院，推動了對骨科植入物的需求。獸醫骨科領域正在進行的研究和開發工作正在推動創新，使治療程序更加有效和便利。隨著植入技術的不斷進步和寵物護理支出的增加，北美仍然是獸醫骨科植入物市場的主導力量。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 狗狗骨科疾病發生率不斷上升
    • 獸醫骨科技術的進步
    • 擴大寵物保險覆蓋範圍
  • 產業陷阱與挑戰
    • 骨科手術和植入物費用高昂
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按產品，2021 年至 2034 年

• 主要趨勢
• 植入物
  • 盤子
    • TPLO板
    • TTA板
    • 特種板材
    • 創傷板
    • 其他板塊
  • 關節植入物
  • 骨螺絲和錨
  • 針腳和電線
  • 其他植入物
• 儀器

第6章：市場估計與預測：依動物類型，2021 年至 2034 年

• 主要趨勢
• 伴侶動物
  • 狗
  • 貓
  • 其他伴侶動物
• 家畜

第7章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 脛骨平台平整截骨術（TPLO）
• 脛骨結節推進術（TTA）
• 關節置換
  • 髖關節置換術
  • 膝關節置換術
  • 手肘關節置換術
  • 踝關節置換術
• 創傷
• 其他應用

第8章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 獸醫醫院和診所
• 其他最終用途

第9章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• AmerisourceBergen Corporation
• Arthrex Vet Systems
• B. Braun SE
• BlueSAO
• BioMedtrix
• DePuy Synthes (Johnson & Johnson)
• Fusion Implants
• Integra LifeSciences
• Kyon
• Movora (Vimian Group AB)
• Narang Medical Limited
• Orthomed
• Ortho Max
• Veterinary Instrumentation
• STERIS

The Global Veterinary Orthopedic Implants Market was valued at USD 617 million in 2024 and is projected to expand at a CAGR of 7.7% from 2025 to 2034. The rising prevalence of orthopedic disorders and musculoskeletal injuries in animals is a key factor driving market growth. As more pets and livestock develop mobility-related issues, the demand for advanced surgical solutions continues to surge. Veterinary professionals are increasingly adopting orthopedic implants to improve treatment outcomes, while technological advancements in implant materials and design are enhancing surgical precision.

Pet owners are becoming more proactive about their animal's health, fueling demand for specialized orthopedic procedures. The growing awareness of treatment options, in line with improved diagnostic capabilities, is leading to higher adoption rates for veterinary implants. The increasing number of veterinarians trained in orthopedic procedures and the expansion of veterinary clinics with advanced surgical capabilities are further accelerating market expansion. Additionally, the rise in pet insurance policies covering orthopedic procedures is encouraging pet owners to opt for surgeries, further propelling the adoption of veterinary orthopedic implants.

The implants segment dominated the market, generating USD 401 million in 2024, primarily due to the growing need for surgical interventions in animals with orthopedic injuries. Veterinary professionals are relying more on plates, bone screws, joint implants, and other surgical devices to treat fractures, ligament tears, and joint disorders. The rising number of procedures addressing these conditions is pushing demand for advanced implant designs that offer greater precision, reduce recovery time, and enhance mobility in treated animals. Minimally invasive surgical techniques are gaining traction as they provide more efficient solutions for treating musculoskeletal conditions with reduced post-operative complications.

Companion animals accounted for a dominant 72.5% share of the veterinary orthopedic implants market in 2024, driven by a significant surge in pet adoption. With more households worldwide owning pets, particularly dogs and cats, spending on veterinary care has increased. Pet owners are investing more in orthopedic treatments to improve their pets' quality of life, leading to higher demand for specialized implants. The trend of humanizing pets-where owners view animals as family members-is further contributing to market expansion.

North America led the global market, holding a 45.2% share in 2024, supported by high pet ownership rates and an advanced veterinary healthcare infrastructure. The region's strong presence of specialized veterinary clinics and hospitals equipped with state-of-the-art surgical technologies has boosted demand for orthopedic implants. Ongoing research and development efforts in veterinary orthopedics are driving innovation, making procedures more effective and accessible. With continued advancements in implant technology and increasing pet care expenditure, North America remains a dominant force in the veterinary orthopedic implants market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of orthopedic conditions in dogs
    • 3.2.1.2 Advancements in veterinary orthopedic technology
    • 3.2.1.3 Expansion of pet insurance coverage
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of orthopedic procedures and implants
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Implants
  • 5.2.1 Plates
    • 5.2.1.1 TPLO plates
    • 5.2.1.2 TTA plates
    • 5.2.1.3 Specialty plates
    • 5.2.1.4 Trauma plates
    • 5.2.1.5 Other plates
  • 5.2.2 Joint implants
  • 5.2.3 Bone screws and anchors
  • 5.2.4 Pins and wires
  • 5.2.5 Other implants
• 5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Other companion animals
• 6.3 Livestock animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Tibial Plateau Leveling Osteotomy (TPLO)
• 7.3 Tibial Tuberosity Advancement (TTA)
• 7.4 Joint replacement
  • 7.4.1 Hip replacement
  • 7.4.2 Knee replacement
  • 7.4.3 Elbow replacement
  • 7.4.4 Ankle replacement
• 7.5 Trauma
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals and clinics
• 8.3 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 AmerisourceBergen Corporation
• 10.2 Arthrex Vet Systems
• 10.3 B. Braun SE
• 10.4 BlueSAO
• 10.5 BioMedtrix
• 10.6 DePuy Synthes (Johnson & Johnson)
• 10.7 Fusion Implants
• 10.8 Integra LifeSciences
• 10.9 Kyon
• 10.10 Movora (Vimian Group AB)
• 10.11 Narang Medical Limited
• 10.12 Orthomed
• 10.13 Ortho Max
• 10.14 Veterinary Instrumentation
• 10.15 STERIS